REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,660,767 | +1420.0% | 54,155 | +1912.4% | 0.29% | +1345.0% |
Q3 2022 | $504,000 | +10.5% | 2,691 | -4.2% | 0.02% | 0.0% |
Q2 2022 | $456,000 | -76.5% | 2,808 | -72.7% | 0.02% | -75.9% |
Q1 2022 | $1,937,000 | +226.1% | 10,297 | +359.1% | 0.08% | +124.3% |
Q4 2021 | $594,000 | +1.0% | 2,243 | -43.7% | 0.04% | -68.6% |
Q3 2020 | $588,000 | – | 3,984 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |